25.04.2013
- GlaxoSmithKline is to sell soft drink brands Lucozade and Ribena in a move analysts believe will raise over 1 billion pounds ($1.5 billion) and focus its consumer health business...
11.04.2013
- Headlines frequently state that shale gas is a "game changer". A game usually implies that there are winners and losers among its participants. However, the shale gas game is not...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
25.02.2013
- Investment firm Royalty Pharma has made a $6.6 billion bid approach to Elan, seeking to scupper the Irish drugmaker's plan to spend most of the proceeds from a major drug sale on...
21.02.2013
- Europe's hard-pressed refining industry faces more closures as its competition in the United States enjoys the double bonus of growing domestic shale oil supply and cheaper...
07.02.2013
- French drugmaker Sanofi said earnings could fall this year as it continues to feel the effects of expiring patents, disappointing hopes of a return to growth. The group, which saw...
31.01.2013
- Dow Chemical posted lower-than-expected adjusted profit on Thursday, as demand withered for polyurethane and chlorine around the world, especially in China and Europe. For the...
30.01.2013
- Thermo Fisher Scientific is considering making an offer for Life Technologies, the biomedical laboratory equipment maker that is exploring a potential sale, three people familiar...
18.01.2013
- Life Technologies is exploring a potential sale and has retained banks to advise on the process, sending shares of the biotechnology company 11% higher to an all-time high on...
16.01.2013
- Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...
